582
Á. Díaz-Ortiz et al.
LETTER
(6) (a) Hurst, D. T. Prog. Heterocycl. Chem. 1995, 7, 244.
(b) Groger, H.; Sans, J.; Gunther, T. Chim. Oggi 2000, 18,
12. (c) Neunhoffer, H. In Comprehensive Heterocyclic
Chemistry, Vol. 3; Katrizky, A. R.; Rees, C. W.; Boulton, A.
J.; McKilop, A., Eds.; Pergamon: Oxford, 1984.
(7) (a) Hirata, K.; Nakagami, H.; Takashina, J.; Miyamoto, K.
Heterocycles 1996, 43, 1513. (b) Abdel-Rahman, R. M.;
Seada, M.; Fawly, M.; El-Baz, I. Farmaco 1993, 48, 397.
(8) (a) Häufel, J.; Breitmaier, E. Angew. Chem., Int. Ed. Engl.
1974, 13, 604. (b) Wustrow, D. J.; Capiris, T.; Rubin, R.;
Knobelsdorf, J. A.; Akunne, H.; Davis, M. D.; MacKenzie,
R.; Pugsley, T. A.; Zoski, K. T.; Heffner, T. G.; Wise, D. L.
Bioorg. Med. Chem. Lett. 1998, 8, 2067.
(9) (a) Menozzi, G.; Mestri, L.; Fossa, P.; Mattioli, F.; Ghia, M.
J. Heterocycl. Chem. 1997, 34, 963. (b) Penning, T. D.;
Talley, J. J.; Bertenshaw, S. R.; Carter, J. S.; Collins, P. W.;
Docter, S.; Graneto, M. J.; Lee, L. F.; Malecha, J. W.;
Miyashiro, J. M.; Rogers, R. S.; Rogier, D. J.; Yu, S. S.;
Anderson, G. D.; Burton, G. D.; Cogburn, J. N.; Gregory, S.
A.; Kobodt, C. M.; Perkins, W. E.; Seibert, K.; Veenhuizen,
A. W.; Zhang, Y. Y.; Isakson, P. C. J. Med. Chem. 1997, 40,
1347.
(10) (a) Habib, N. S.; Tawil, G. G. Sci. Pharm. 1981, 49, 42.
(b) Devi, S.; Mitro, P.; Mishra, S. B.; Mittra, A. S. J. Indian
Chem. Soc. 1983, 60, 679. (c) Daidone, G.; Maggio, B.;
Plescia, S.; Raffa, D.; Musiu, C.; Milia, C.; Perra, G.;
Marongiu, M. E. Eur. J. Med. Chem. 1998, 33, 375. (d) El-
Emary, T. I.; Bakhite, E. A. Pharmazie 1999, 54, 106.
(11) (a) Alvarez, R.; Velazquez, S.; San-Felix, A.; Aquaro, S.; De
Clercq, E.; Perno, C.-F.; Karlsson, A.; Balzarini, J.;
Camarasa, M. J. J. Med. Chem. 1994, 37, 4185. (b) Ölgen,
S.; Chung, K. C. Z. Naturforsch., B: Chem. Sci. 2001, 56,
804.
(15) Experimental Procedure.
A mixture of bromoderivative (1 equiv), NaI (5 equiv if 1 is
employed or 3 equiv in the case of 2 and 3), DMF (0.1 mL)
and the corresponding dienophile (2 equiv) was placed in an
open vessel and irradiated at 10 W in a focused microwave
reactor (Discover®, CEM) for 15 min. The crude product
was purified by flash column chromatography (silica gel,
Merck type 60, 230–400 mesh) using hexane–EtOAc as the
eluent to obtain the adduct.
Data for 8: mp 204–205 °C. 1H NMR (500 MHz, CDCl3):
d = 3.35 (s, 3 H, CH3), 8.60 (s, 1 H, H-5), 9.05 (s, 1 H, H-9),
10.14 (s, 1 H, H-3) ppm. 13C NMR (125 MHz, CDCl3):
d = 25.0 (CH3), 126.0 (C-5), 126.3 (C-9), 132.2, 135.7 (C-9a
and -4a), 143.9, 149.6 (C-8a and -5a), 165.6 (C=O). MS (EI):
m/z = 214 [M+].
Data for 10: mp 165.5–166.5 °C. 1H NMR (500 MHz,
CDCl3): d = 2.86 (dd, 1 H, J = 7.3, 15.4 Hz, H-4), 2.90 (s, 3
H, CH3), 2.93 (dd, 1 H, J = 7.3, 16.1 Hz, H-10), 3.23 (dd, 1
H, J = 1.6, 15.4 Hz, H-4), 3.34 (dd, 1 H, J = 1.6, 7.3 Hz, H-
5), 3.36 (dd, 1 H, J = 1.8, 7.3 Hz, H-9), 3.55 (dd, 1 H, J = 1.8,
16.1 Hz, H-10), 7.37 (t, 1 H, J = 6.3 Hz, p-H Ph), 7.44 (t, 2
H, J = 6.3 Hz, m-H Ph), 7.46 (t, 2 H, J = 6.3 Hz, o-H Ph),
7.47 (s, 1 H, H-3) ppm. 13C NMR (125 MHz, CDCl3): d =
21.1 (C-4), 21.7 (C-10), 25.3 (CH3), 39.6, 39.9 (C-5 and -9),
123.5 (m-C), 127.5 (p-C), 129.3 (o-C), 137.7 (C-3), 179.0,
179.4 (C=O), 115.2, 135.9, 139.1 ppm. MS (EI): m/z 281
[M+].
Data for 16: yellow oil. 1H NMR (500 MHz, CDCl3): d =
1.26 (m, 6 H, 2 × CH3), 4.21 (m, 4 H, 2 × CH2), 4.51 (br s, 2
H, H-4a and -7a), 5.30 (br s, 2 H, H-4b and -7b), 7.54 (m, 5
H, Ph) ppm. 13C NMR (125 MHz, CDCl3): d = 14.4 (CH3),
42.0, 44.3 (C-4 and -7), 63.2 (COOCH2), 122.3 (p-C), 129.3
(m-C), 129.9 (o-C), 140.7 (ipso-C), 155.3, 155.6 (COO),
136.3 ppm. MS (EI): m/z = 345 [M+].
(12) Genin, M. J.; Alwine, D. A.; Anderson, D. J.; Barbachyn, M.
R.; Emmert, D. E.; Garmon, S. A.; Graber, D. R.; G rega, K.
C.; Hester, J. B.; Hutchison, D. K.; Morris, J.; Reischer, R.
J.; Ford, C. W.; Zurenko, G. E.; Hamel, J. C.; Schaadt, R. D.;
Stapert, D.; Yagi, B. H. J. Med. Chem. 2000, 43, 953.
(13) Brockunier, L. L.; Parmee, E. R.; Ok, H. O.; Candelore, M.
R.; Cascieri, M. A.; Colwell, L. F.; Deng, L.; Feeney, W. P.;
Forrest, M. J.; Hom, G. J.; MacIntyre, D. E.; Tota, L.;
Wyvratt, M. J.; Fisher, M. H.; Weber, A. E. Bioorg. Med.
Chem. Lett. 2000, 10, 2111.
(16) Shepherd, M. K. J. Chem. Soc., Perkin Trans. 1 1986, 1495.
(17) Leadbeater, N. E.; Torenius, H. M.; Tye, H. Tetrahedron
2003, 59, 2253.
(18) Experimental Procedure.
A mixture of hydroxyderivative 17 or 18 (1 equiv), ionic
liquid 19 (2.8 equiv), PTSA (2 equiv) and xylene (1 mL) was
placed in an closed vessel and irradiated at 15 W in a focused
microwave reactor (Discover®, CEM) for 3.5 min (final
temperature 150 °C). The organic layer was separated from
this two-phase system. The ionic liquid was washed with
xylene (2 × 1 mL). The combined organic layers were dried
with MgSO4 and the solvent removed at reduced pressure.
The resulting bromoderivatives, 2 or 3, can be directly
employed or purified by flash column chromatography
(silica gel, Merck type 60, 230–400 mesh) using hexane–
EtOAc 2:1 as the eluent.
(14) (a) Mitkidou, S.; Stephanidou-Stephanatou, J. Tetrahedron
Lett. 1990, 31, 5197. (b) Mertzanos, G. E.; Stephanidou-
Stephanatou, J.; Tsoleridis, C. A.; Alexandrou, N. E.
Tetrahedron Lett. 1992, 33, 4499.
Synlett 2006, No. 4, 579–582 © Thieme Stuttgart · New York